Cargando…
Vaccine responses in newborns
Immunisation of the newborn represents a key global strategy in overcoming morbidity and mortality due to infection in early life. Potential limitations, however, include poor immunogenicity, safety concerns and the development of tolerogenicity or hypo-responsiveness to either the same antigen and/...
Autores principales: | Saso, Anja, Kampmann, Beate |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711983/ https://www.ncbi.nlm.nih.gov/pubmed/29124321 http://dx.doi.org/10.1007/s00281-017-0654-9 |
Ejemplares similares
-
Vaccine-Induced Cellular Immunity against Bordetella pertussis: Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of Novel Pertussis Vaccines
por: Saso, Anja, et al.
Publicado: (2021) -
Impact of COVID-19 on Immunization Services for Maternal and Infant Vaccines: Results of a Survey Conducted by Imprint—The Immunising Pregnant Women and Infants Network
por: Saso, Anja, et al.
Publicado: (2020) -
Maternal Immunization: Nature Meets Nurture
por: Saso, Anja, et al.
Publicado: (2020) -
Prioritising immunisation across the life course
por: Saso, Anja, et al.
Publicado: (2021) -
Challenges for the Newborn Immune Response to Respiratory Virus Infection and Vaccination
por: Crofts, Kali F., et al.
Publicado: (2020)